Johannes Haubold
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Johannes Haubold has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Felix Nensa
Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
1 shared publicationGregor Jost
Bayer AG, Berlin, Germany
1 shared publicationHubertus Pietsch
Bayer AG, Berlin, Germany
1 shared publicationJannis Straus
Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany
1 shared publication- Johannes Christian Harmes
Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
1 shared publication Luca Salhöfer
Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
1 shared publication
Latest Publications
- Open Access
- 28 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Radiation dose has no significant impact on CT-based bone mineral density measurements in a large-animal model
Bone mineral density (BMD) is a biomarker for frailty, and CT-derived radiodensity can be extracted fully automatically as a surrogate. Because these measurements might be affected by image noise, which varies substantially in the clinical routine, this systematic large-animal study investigates the consistency of CT-based BMD measurements under different radiation dose settings. Twenty Göttingen minipigs underwent six non-contrast CT examinations with five dose levels (CTDIvol: 0.53–10.01 mGy; 5%, 10%, 20%, 40%, 100%; 600 scans). BMD was assessed using CT-derived radiodensity (Hounsfield units, HU) by segmenting the complete ninth thoracic vertebra, and by placing a region of interest (ROI) in the trabecular bone. RM-ANOVA was used to assess statistical significance. Data are presented as mean with standard deviation. The BMD measurement remained consistent between the control and the different dose settings. Even the lowest dose setting (5%: complete = 761 [± 56] HU, ROI = 749 [± 72] HU) showed no significant differences compared to the control (complete = 756 [± 55] HU, ROI = 738 [± 68] HU). Finally, CT-based BMD measurements remained consistent and are therefore robust to substantial dose reduction, indicating the technical feasibility of comparing CT examinations with different dose protocols, relevant for opportunistic screening.
- 28 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessRadiation dose has no significant impact on CT-based bone mineral density measurements in a large-animal model
Bone mineral density (BMD) is a biomarker for frailty, and CT-derived radiodensity can be extracted fully automatically as a surrogate. Because these measurements might be affected by image noise, which varies substantially in the clinical routine, this systematic large-animal study investigates the consistency of CT-based BMD measurements under different radiation dose settings. Twenty Göttingen minipigs underwent six non-contrast CT examinations with five dose levels (CTDIvol: 0.53–10.01 mGy; 5%, 10%, 20%, 40%, 100%; 600 scans). BMD was assessed using CT-derived radiodensity (Hounsfield units, HU) by segmenting the complete ninth thoracic vertebra, and by placing a region of interest (ROI) in the trabecular bone. RM-ANOVA was used to assess statistical significance. Data are presented as mean with standard deviation. The BMD measurement remained consistent between the control and the different dose settings. Even the lowest dose setting (5%: complete = 761 [± 56] HU, ROI = 749 [± 72] HU) showed no significant differences compared to the control (complete = 756 [± 55] HU, ROI = 738 [± 68] HU). Finally, CT-based BMD measurements remained consistent and are therefore robust to substantial dose reduction, indicating the technical feasibility of comparing CT examinations with different dose protocols, relevant for opportunistic screening.